Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ImClone and Merck KGaA initiate first international phase III trial center of C225

Dec. 6, 1999

Maret initiates clinical development of MARstem for chemotherapy-induced neutropenia

Dec. 3, 1999

Foscan NDA accepted for review

Dec. 3, 1999

Liposomal vinorelbine: design and preliminary characterization in vitro and in vivo

Dec. 1, 1999

Eukarion awarded SBIR grant to develop treatment for radiation damage

Dec. 1, 1999

MMP inhibitor NF-681 targets renal cell carcinoma

Dec. 1, 1999

Team from P&G discovers new use for an old drug

Dec. 1, 1999

Efficacy of FXR-targeting therapy validated by Symphar-Ilex team

Dec. 1, 1999

3-DP investigators study role of MMP in tumor angiogenesis

Nov. 30, 1999

Sindan and Pfizer team up to develop new multitargeted antifolate

Nov. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...